Corbin, J. G., D. Kelly, E. M. Rath, K. D. Baerwald, K. Suzuki, and B.
Popko. 1996. Targeted CNS expression of interferon-gamma in transgenic
mice leads to hypomyelination, reactive gliosis, and abnormal cerebral de-velopment. Mol. Cell. Neurosci. 7:354–370.
Da ̈ubener, W., C. Remscheid, S. Nockmann, K. Pilz, S. Seghrouchni, C.
MacKenzie, and U. Hadding. 1996. Antiparasitic effector mechanism in
human brain tumor cells: role of interferon-gamma and tumor necrosis
factor-alpha. Eur. J. Immunol. 26:487–492.
Da ̈ubener, W., N. Wanagat, K. Pilz, S. Seghrouchni, H. G. Fischer, and U.
Hadding. 1994. A new, simple, bioassay for human IFN-gamma. J. Immunol.
Methods 168:39–47.
Duprex, W. P., S. McQuaid, L. Hangartner, M. A. Billeter, and B. K. Rima.
1999. Observation of measles virus cell-to-cell spread in astrocytoma cells by
using a green fluorescent protein-expressing recombinant virus. J. Virol. 73:
9568–9575.
Eneroth, A., T. Andersson, T. Olsson, C. Orvell, E. Norrby, and K. Kristensson. 1992. Interferon-gamma-like immunoreactivity in sensory neurons
may influence the replication of Sendai and mumps viruses. J. Neurosci. Res.
31:487–493.
Eneroth, A., K. Kristensson, A. Ljungdahl, and T. Olsson. 1991. Interferongamma-like immunoreactivity in developing rat spinal ganglia neurons in
vivo and in vitro. J. Neurocytol. 20:225–231.
Finke, D., U. G. Brinckmann, V. ter Meulen, and U. G. Liebert. 1995.
Gamma interferon is a major mediator of the antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:5469–5474.
Frese, M., V. Schwarze, K. Barth, N. Kriegr, V. Lohmann, S. Mihm, O.
Haller, and R. Bartenschlager. 2002. Interferon-gamma inhibits replication
of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35:694–703.
Frumento, G., R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G. B.
Ferrara. 2002. Tryptophan-derived catabolites are responsible for inhibition
of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196:459–468.
Fujigaki, S., K. Saito, K. Sekikawa, S. Tone, O. Takikawa, H. Fuji, H. Wada,
A. Noma, and M. Seishima. 2001. Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent
mechanism. Eur. J. Immunol. 31:2313–2318.
Grant, R. S., H. Naif, S. J. Thuruthyil, N. Nasr, T. Littlejohn, O. Takikawa,
and V. Kapoor. 2000. Induction of indoleamine 2,3-dioxygenase in primary
human macrophages by human immunodeficiency virus type 1 is strain de-pendent. J. Virol. 74:4110–4115.
Guillemin, G. J., G. Smythe, O. Takikawa, and B. J. Brew. 2005. Expression
of indolamine 2,3-dioxygenase and production of quinolinic acid by human
microglia, astrocytes, and neurons. Glia 49:15–23.
Gupta, S. L., J. M. Carlin, P. Pyati, W. Dai, E. R. Pfefferkorn, and M. J.
Murphy, Jr. 1994. Antiparasitic and antiproliferative effects of indoleamine
2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62:
2277–2284.
Habara-Ohkubo, A., T. Shirahata, O. Takikawa, and R. Yoshida. 1993.
Establishment of an antitoxoplasma state by stable expression of mouse
indoleamine 2,3-dioxygenase. Infect. Immun. 61:1810–1813.
Hara, T., S. Yamashita, H. Aiba, K. Nihei, N. Koide, R. A. Good, and K.
Takeshita. 2000. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J. Neurovirol. 6:121–126.
Heyes, M. P., C. Y. Chen, E. O. Major, and K. Saito. 1997. Different
kynurenine pathway enzymes limit quinolinic acid formation by various hu-man cell types. Biochem. J. 326:351–356.
Komatsu, T., Z. Bi, and C. S. Reiss. 1996. Interferon-gamma induced type I
nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:101–108.
Ku ̈ndig, T. M., H. Hengartner, and R. M. Zinkernagel. 1993. T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but
not in peripheral solid organs. J. Immunol. 150:2316–2321.
MacKenzie, C. R., R. Langen, O. Takikawa, and W. Da ̈ubener. 1999. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma induced bacteriostasis but does not abrogate toxoplasmostasis.
Eur. J. Immunol. 29:3254–3261.
Maloney, E. M., M. O. St. Clair, B. Widner, E. R. Werner, and D. Fuchs.
2000. Central nervous system activation of the indoleamine 2,3-dioxygenase
pathway in human T cell lymphotropic virus type I-associated myelopathy/
tropical spastic paraparesis. J. Infect. Dis. 181:2037–2040.
Marin, V., G. Kaplanski, S. Gr`es, C. Farnarier, and P. Bongrand. 2001.
Endothelial cell culture: protocol to obtain and cultivate human umbilical
endothelial cells. J. Immunol. Methods 254:183–190.
Mellor, A. L., J. Sivakumar, P. Chandler, K. Smith, H. Molina, D. Moao, and
D. H. Munn. 2001. Prevention of T cell-driven complement activation and
inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2:
64–68.
Moffett, J. R., and M. A. Namboodiri. 2003. Tryptophan and the immune
response. Immunol. Cell Biol. 81:247–265.
Munn, D. H., and A. L. Mellor. 2004. IDO and tolerance to tumors. Trends
Mol. Med. 1:15–18.
Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and
